Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Dexamethasone results

press releases

16 June 2020

Statement from the Chief Investigators: low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19

Comunicado dos Pesquisadores Principais do estudo “Avaliação randomizada de terapias para a COVID-19” (RECOVERY) sobre dexametasona, 16 de junho de 2020

Comunicado de prensa de la Universidad de Oxford: Dexametasona reduce la mortalidad hasta un tercio en pacientes hospitalizados con complicaciones severas por COVID-19

publications

12 april 2023

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label platform trial published in The Lancet.

16 December 2022

The results of higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support published on medRxiv. 

25 February 2021

Dexamethasone in Hospitalized Patients with Covid-19, published in The New England Journal of Medicine. 

2 September 2020

Meta-analysis including the RECOVERY trial published in JAMA.

22 june 2020

Preliminary results of the dexamethasone comparison published on medRxiv.